Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
AU604793B2 - Env/gag-polypeptides - Google Patents
[go: Go Back, main page]

AU604793B2 - Env/gag-polypeptides - Google Patents

Env/gag-polypeptides

Info

Publication number
AU604793B2
AU604793B2 AU81909/87A AU8190987A AU604793B2 AU 604793 B2 AU604793 B2 AU 604793B2 AU 81909/87 A AU81909/87 A AU 81909/87A AU 8190987 A AU8190987 A AU 8190987A AU 604793 B2 AU604793 B2 AU 604793B2
Authority
AU
Australia
Prior art keywords
env
gag
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU81909/87A
Other versions
AU8190987A (en
Inventor
Reiner Gentz
Stuart Le Grice
Jan Mous
Dietrich Stuber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU8190987A publication Critical patent/AU8190987A/en
Application granted granted Critical
Publication of AU604793B2 publication Critical patent/AU604793B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU81909/87A 1986-12-05 1987-11-30 Env/gag-polypeptides Ceased AU604793B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629116A GB8629116D0 (en) 1986-12-05 1986-12-05 Env/gag polypeptides
GB8629116 1986-12-05

Publications (2)

Publication Number Publication Date
AU8190987A AU8190987A (en) 1988-06-16
AU604793B2 true AU604793B2 (en) 1991-01-03

Family

ID=10608515

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81909/87A Ceased AU604793B2 (en) 1986-12-05 1987-11-30 Env/gag-polypeptides

Country Status (5)

Country Link
EP (1) EP0270114A3 (en)
JP (1) JPS63156729A (en)
AU (1) AU604793B2 (en)
GB (1) GB8629116D0 (en)
NZ (1) NZ222766A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
GB2220939B (en) * 1988-06-10 1992-02-26 Medical Res Council Peptide fragments of hiv and their use in vaccines and diagnosis
JPH0748276A (en) * 1992-03-26 1995-02-21 Inmeru:Kk Preventing vaccine for hiv infectious disease and production thereof
DE4405810A1 (en) 1994-02-23 1995-08-24 Behringwerke Ag Peptides derived from a retrovirus from the HIV group and their use
NO311807B1 (en) 1999-03-04 2002-01-28 Bionor Immuno As HIV peptides, antigens, vaccine preparations, immunoassay test kits and a method for detecting antibodies induced by HIV
AU2013273481B2 (en) 2012-06-06 2018-04-05 Bionor Immuno As HIV vaccine
WO2016005508A1 (en) 2014-07-11 2016-01-14 Bionor Immuno As Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152928A (en) * 1982-03-06 1983-09-10 Hiroshi Teramachi Four-way loaded linear bearing

Also Published As

Publication number Publication date
EP0270114A2 (en) 1988-06-08
NZ222766A (en) 1990-09-26
EP0270114A3 (en) 1990-01-17
GB8629116D0 (en) 1987-01-14
JPS63156729A (en) 1988-06-29
AU8190987A (en) 1988-06-16

Similar Documents

Publication Publication Date Title
AU591007B2 (en) 3-aryloxy-3-substituted propanamines
AU7310987A (en) 1-aralkyl-4-cyano-pyrazoles
AU7931887A (en) Imidazo-benzoxazinones
AU593093B2 (en) Radio-direction-finding
AU6628986A (en) Tots-in-tandem
AU7024087A (en) Groundsheet
AU7553887A (en) 7-acyloxy-6-aminoacyloxypolyoxylabdanes
AU6925587A (en) Naphthothiazepinones
AU8063287A (en) Triazolo-pyrimidine-2-sulphonamides
AU5988990A (en) 3-alkoxy-2-aminopropylamides
AU7686987A (en) Triazolo-pryimidine-2-sulphonamides
AU7372487A (en) Fire-lighters
AU6876687A (en) Theft-deterring label-holders
AU7562487A (en) Dartboards
AU579047B2 (en) Pyridopyrimidinediones
AU626472B2 (en) 1-n-dodecylazacycloheptane-2-thione
AU604793B2 (en) Env/gag-polypeptides
AU7182187A (en) 3-carbamoyl-4-hydroxy-coumarins
AU7432087A (en) Roller-ski
AU6804587A (en) 4-aminomethyl-fluoresceins
AU6791287A (en) Sky-light
AU7769287A (en) 2-oxo-4-carboxy-pyrimidines
AU7725887A (en) 5-substituted-3-phenyl-3-(1h-imidazoyl-1-ylmethyl)-2-methyl- isoxazolidines
AU7594487A (en) Decahydronaphth-2-yl-alkylamines
AU8187487A (en) 1-aryloxy-3-amino-2-propanols